FDA DEVICE FACTS
mGRIP Total Prosthesis (3.00 mm) (58689); mGRIP Total Prosthesis (3.25 mm) (58691); mGRIP Total Prosthesis (3.50 mm) (58693); mGRIP Total Prosthesis (3.75 mm) (58695); mGRIP Total Prosthesis (4.00 mm) (58697); mGRIP Total Prosthesis (4.25 mm) (58699); mGRIP Total Prosthesis (4.50 mm) (58701); mGRIP Total Prosthesis (4.75 mm) (58703); mGRIP Total Prosthesis (5.00 mm) (58705); mGRIP Total Prosthesis (5.50 mm) (58707); mGRIP Total Prosthesis (6.00 mm) (58709); mGRIP Total Prosthesis (6.50
MED-EL Elektromedizinische Geräte GmbH
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
INTENDED USE The passive middle ear implant—tympanoplasty total prosthesis—is intended to be used for replacement of components of the ossicular chain if at least the stapes footplate is present and functional. The tympanoplasty total prosthesis is implanted in the middle ear to restore sound transmission from the tympanic membrane to the oval window by replacing the ossicles totally. The tympanoplasty prosthesis is a sterile, single-use medical device. INTENDED USER The tympanoplasty prosthesis is intended to be implanted only by qualified ENT surgeons with adequate skills to perform otological surgery. Replacement of the ossicular chain is a standard surgical procedure; no additional device-specific training is mandatory or required for safe and effective use. TARGET PATIENT POPULATION The target patient population for the passive middle ear implant is patients of all ages requiring reconstruction of the ossicular chain. INDICATIONS The tympanoplasty prosthesis is indicated to treat patients with:
- Congenital or acquired ossicular-chain defects, for example chronic otitis media, traumatic injury, malformation, or cholesteatoma.
- Inadequate conductive hearing from previous middle ear surgery. The total ossicular replacement prosthesis is indicated if at least the stapes footplate is present and functional.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。